Table 2 Characteristics of included studies
Chao et al. 2015 [33] (Chronic pelvic pain) n = 26 | Harrison & Lach 2017 [32] (PCOS) n = 11 | Prescott et al. 2016 [34] (Gynaecological cancers) n = 105 | Schneeberger et al. 2019 [35] (Breast cancer) n = 21 | ||
|---|---|---|---|---|---|
Study design | Feasibility | x | x | x | |
Pilot | x | x | x | ||
Quasi-experimental | x | ||||
Non-randomised & uncontrolled | x | x | |||
Feasibility outcomes | Quantitative feasibility measures | x | x | x | x |
Qualitative feasibility feedback | x | x | |||
Clinical outcomes | Chronic Disease Self-Efficacy Scale | x | |||
Biometric outcomes | x | ||||
Psychosocial metrics | x | ||||
Patient reported questionnaires (e.g. quality of life, pain scales) | x | x | |||
Dietary screening | x | ||||